ADEFISAN, ADEDOYIN OMOBOLANLE
(2023-02)
Breast cancer (BC) remains a disease with high morbidity and mortality. In Nigeria,
BC represents about 23% of all cancer cases. Currently available chemotherapeutic
interventions are associated with significant adverse ...